Skip to main content

. 1992 Oct 15;147(8):1239–1241.

Growing number of elderly patients will mean more ethical issues for MDs, conference told.

PMCID: PMC1336503 PMID: 1393941

1239

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Myllylä V. V., Sotaniemi K. A., Vuorinen J. A., Heinonen E. H. Selegiline as initial treatment in de novo parkinsonian patients. Neurology. 1992 Feb;42(2):339–343. doi: 10.1212/wnl.42.2.339. [DOI] [PubMed] [Google Scholar]
Tetrud J. W., Langston J. W. The effect of deprenyl (selegiline) on the natural history of Parkinson's disease. Science. 1989 Aug 4;245(4917):519–522. doi: 10.1126/science.2502843. [DOI] [PubMed] [Google Scholar]

ACTIONS

PDF (606.9 KB)

RESOURCES